Day: February 12, 2021
VANCOUVER, British Columbia, Feb. 11, 2021 (GLOBE NEWSWIRE) — Solstice Gold Corporation (TSXV:SGC) (“Solstice”, the “Company”, “we” or “our”) is pleased to announce that, further to our news release dated February 2, 2021 and following receipt of approval from the TSX Venture Exchange, the Company has issued to Gravel Ridge Resources Ltd. (“Gravel Ridge”) 300,000 common shares (“Common Shares”) as a portion of the consideration payable by the Company to Gravel Ridge in connection with the option agreement (“Agreement”) dated February 1, 2021 (“Effective Date”) for an option (“Option”) to acquire a 100% interest in the Red Lake Extension project (the “Project”). In accordance with the terms and conditions of the Agreement, the Company has also paid $22,000 to Gravel Ridge on the Effective Date.Pursuant to the Agreement, to fully...
U.S. Energy Corp. Announces Pricing of $5.0 Million Underwritten Public Offering of Common Stock
Written by Customer Service on . Posted in Public Companies.
HOUSTON, Feb. 11, 2021 (GLOBE NEWSWIRE) — U.S. Energy Corp. (Nasdaq: USEG) (the “Company”), today announced the pricing of an underwritten public offering of 984,000 shares of its common stock at a price of $5.10 per share, for gross proceeds to the Company of $5,018,400, before deducting underwriting discounts and other offering expenses.In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 147,600 shares of common stock offered in the public offering to cover over-allotments, if any.Kingswood Capital Markets, division of Benchmark Investments, Inc., is acting as sole bookrunner for the offering.The offering is expected to close on February 17, 2021, subject to customary closing conditions.The shares of common stock are being offered by the Company pursuant to a “shelf”...
Willow Biosciences Announces Increase to Bought Deal Offering from $20.0 Million to $25.0 Million
Written by Customer Service on . Posted in Public Companies.
NOT FOR DISTRIBUTION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW.VANCOUVER, British Columbia, Feb. 11, 2021 (GLOBE NEWSWIRE) — Willow Biosciences Inc. (“Willow” or the “Company“) (TSX: WLLW; WLLW.WT; OTCQX: CANSF) is pleased to announce that in connection with its previously announced bought deal offering, Willow and the syndicate of underwriters co-led by Eight Capital and BMO Capital Markets (collectively, the “Underwriters“), have agreed to increase the size of the bought deal offering. Willow will now issue 15,152,000 common shares of the Company (the “Common Shares”) at a price of $1.65 per Common Share (the “Offering Price”) for gross proceeds of approximately $25.0 million (the “Offering”).The Company has also granted...